schizophrenia

News and resources

Month: October 2022

Oct 22 2022

‘Amazing’ Phase 3 Results for Novel Schizophrenia Combo Drug

by Clinical Editor

No Comments

A novel agent that combines xanomeline and trospium (KarXT) provides clinically meaningful benefits in schizophrenia, new results from the phase 3 EMERGENT-2 trial suggest.

Oct 22 2022

Oklahoma executes Benjamin Cole for the murder of his 9-month-old daughter. His attorneys said he had schizophrenia and was mentally ill

by Clinical Editor

No Comments

Oklahoma has executed by lethal injection Benjamin Cole, who was sentenced to death for the 2002 murder of his 9-month-old daughter Brianna Victoria Cole, over the objections of defense attorneys...

Oct 22 2022

Could a Refuted 120-Year-Old Theory Actually Be True? Similarity Between Dementia and Schizophrenia Discovered

by Clinical Editor

No Comments

For the first time, researchers compared schizophrenia and frontotemporal dementia, two conditions that affect the frontal and temporal lobes of the brain. Rarely do researchers in basic science …

Oct 22 2022

Rare Coding Variants May Influence Cognition in Schizophrenia

by Clinical Editor

No Comments

Ultrarare constrained variants (URCVs) may contribute to variance in cognition in patients with schizophrenia, according to a study published online Aug. 17 in …

Oct 21 2022

‘Amazing’ Phase 3 Results for Novel Schizophrenia Combo Drug – Medscape

by Clinical Editor

No Comments

‘Amazing’ Phase 3 Results for Novel Schizophrenia Combo Drug Medscape

Oct 21 2022

Severe COVID-19 Infection May Increase The Risk Of Developing Schizophrenia – IFLScience

by Clinical Editor

No Comments

Severe COVID-19 Infection May Increase The Risk Of Developing Schizophrenia IFLScience

Oct 21 2022

Five Schizophrenia Coping Skills I Can’t Live Without – NAMI

by Clinical Editor

No Comments

Five Schizophrenia Coping Skills I Can’t Live Without NAMI

Oct 21 2022

Schizophrenia: Ultrarare Coding Variant & Cognitive Function – Physician’s Weekly

by Clinical Editor

No Comments

Schizophrenia: Ultrarare Coding Variant & Cognitive Function Physician’s Weekly

Oct 21 2022

Upper cortical layer–driven network impairment in schizophrenia – Science

by Clinical Editor

No Comments

Upper cortical layer–driven network impairment in schizophrenia Science

Oct 21 2022

‘Amazing’ Phase 3 Results for Novel Schizophrenia Combo Drug

by Clinical Editor

No Comments

A novel agent that combines xanomeline and trospium (KarXT) provides clinically meaningful benefits in schizophrenia, new results from the phase 3 EMERGENT-2 trial suggest.